MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$2.44
-0.26 (-9.63%)
As of Mar 29, 10:36 PM ET ·
Financial Highlights (FY 2026)
Revenue
100.41M
Net Income
-31,197,988
Gross Margin
64.5%
Profit Margin
-31.1%
Rev Growth
+42.8%
D/E Ratio
4.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.6% 34.0% 34.0%
Operating Margin -13.4% -12.0% 24.7% 24.4%
Profit Margin -31.1% -29.5% 22.7% 21.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 100.41M 70.32M 27.35M 20.96M
Gross Profit 64.81M 45.39M 9.30M 7.12M
Operating Income -13,414,281 -8,454,970 6.75M 5.11M
Net Income -31,197,988 -19,663,974 6.20M 4.50M
Gross Margin 64.5% 64.6% 34.0% 34.0%
Operating Margin -13.4% -12.0% 24.7% 24.4%
Profit Margin -31.1% -29.5% 22.7% 21.5%
Rev Growth +42.8% +42.8% -0.5% +20.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 50.29M 50.29M 71.52M 80.61M
Total Equity 12.57M 12.57M 72.48M 68.20M
D/E Ratio 4.00 4.00 0.99 1.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,577,118 -5,706,465 9.44M 6.87M
Free Cash Flow 4.10M 4.11M